Literature DB >> 7729872

Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro.

S A Sharma1, M K Tummuru, G G Miller, M J Blaser.   

Abstract

Gastric infection with Helicobacter pylori activates a mucosal inflammatory response by mononuclear cells and neutrophils that includes expression of cytokines interleukin-1 beta (IL-1 beta), IL-6, tumor necrosis factor alpha, and IL-8. In this study, we analyzed the IL-8 response of human gastric cancer cell lines (Kato III, AGS, and MKN28) to H. pylori infection in vitro. IL-8 mRNA expression was detected by reverse transcription-PCR amplification of RNA extracted from epithelial cells after incubation with different H. pylori wild-type and mutant strains, and IL-8 secretion was measured by an enzyme-linked immunosorbent assay. Exposure to viable H. pylori induced IL-8 mRNA and protein synthesis in all three gastric cell lines but not in nongastric epithelial cell lines. Heat-killed H. pylori and a crude cytotoxin preparation did not induce significant IL-8 secretion. IL-8 mRNA peaked between 2 and 4 h postinfection, and IL-8 protein production was maximal 24 h postinfection. Exposure of gastric carcinoma cells to other gastrointestinal bacteria, such as Pseudomonas aeruginosa, Campylobacter jejuni, and Escherichia coli, but not Campylobacter fetus, induced IL-8 synthesis. Wild-type strains that expressed the vacuolating cytotoxin (Tox+) and a cytotoxin-associated gene (cagA) product (CagA+) induced significantly more IL-8 than did CagA- Tox- strains. However, there was no decrease in IL-8 induction by isogenic mutants of CagA-, Tox-, or Cag- Tox- strains or by a mutant lacking the urease subunits. These results indicate that exposure to H. pylori and other gram-negative organisms that do not colonize the gastric mucosa induces IL-8 production by gastric carcinoma cells in vitro. Although the CagA+ Tox+ phenotype of H. pylori is associated with enhanced IL-8 production by gastric cell lines, other bacterial constituents are clearly essential.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729872      PMCID: PMC173210          DOI: 10.1128/iai.63.5.1681-1687.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  Pathogenicity of Helicobacter pylori: a perspective.

Authors:  A Lee; J Fox; S Hazell
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

2.  Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection.

Authors:  L A Noach; N B Bosma; J Jansen; F J Hoek; S J van Deventer; G N Tytgat
Journal:  Scand J Gastroenterol       Date:  1994-05       Impact factor: 2.423

3.  Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori.

Authors:  M K Tummuru; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

4.  Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes.

Authors:  P H Nibbering; O Pos; A Stevenhagen; R Van Furth
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

5.  An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium.

Authors:  P Falk; K A Roth; T Borén; T U Westblom; J I Gordon; S Normark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

6.  Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro.

Authors:  P P Massion; H Inoue; J Richman-Eisenstat; D Grunberger; P G Jorens; B Housset; J F Pittet; J P Wiener-Kronish; J A Nadel
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

7.  Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens.

Authors:  T Borén; P Falk; K A Roth; G Larson; S Normark
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

8.  Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains.

Authors:  T L Cover; M K Tummuru; P Cao; S A Thompson; M J Blaser
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

9.  Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa.

Authors:  J E Crabtree; J I Wyatt; L K Trejdosiewicz; P Peichl; P H Nichols; N Ramsay; J N Primrose; I J Lindley
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

10.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors:  A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

View more
  150 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue.

Authors:  J E Crabtree; D Kersulyte; S D Li; I J Lindley; D E Berg
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

3.  Dynamin is involved in human epithelial cell vacuolation caused by the Helicobacter pylori-produced cytotoxin VacA.

Authors:  J Suzuki; H Ohnsihi; H Shibata; A Wada; T Hirayama; T Iiri; N Ueda; C Kanamaru; T Tsuchida; H Mashima; H Yasuda; T Fujita
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.

Authors:  J Parsonnet; G D Friedman; N Orentreich; H Vogelman
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

5.  Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA.

Authors:  V Ricci; C Ciacci; R Zarrilli; P Sommi; M K Tummuru; C Del Vecchio Blanco; C B Bruni; T L Cover; M J Blaser; M Romano
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

6.  Helicobacter pylori isolated from a patient with Ménétrier's disease increases hepatocyte growth factor mRNA expression in gastric fibroblasts: comparison with Helicobacter pylori isolated from other gastric diseases.

Authors:  Takeshi Ishikawa; Takashi Ando; Hiroshi Obayashi; Nami Nakabe; Mika Okita; Yutaka Isozaki; Yasuyuki Nagao; Hirokazu Oyamada; Yoshihiro Nakajima; Haruki Kato; Satoshi Kokura; Yuji Naito; Norimasa Yoshida; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

Review 7.  Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells.

Authors:  Suneesh Kumar Pachathundikandi; Nicole Tegtmeyer; Steffen Backert
Journal:  Gut Microbes       Date:  2013-11-06

8.  Chemokines and antimicrobial peptides have a cag-dependent early response to Helicobacter pylori infection in primary human gastric epithelial cells.

Authors:  Pascale Mustapha; Isabelle Paris; Magali Garcia; Cong Tri Tran; Julie Cremniter; Martine Garnier; Jean-Pierre Faure; Thierry Barthes; Ivo G Boneca; Franck Morel; Jean-Claude Lecron; Christophe Burucoa; Charles Bodet
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

9.  Relationship between gastric disease and deletion of cag pathogenicity island genes of Helicobacter pylori in gastric juice.

Authors:  Osamu Kawamura; Masami Murakami; Osamu Araki; Takuro Yamada; Sayaka Tomizawa; Yasuyuki Shimoyama; Keiko Minashi; Masaki Maeda; Motoyasu Kusano; Masatomo Mori
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

10.  Aspirin-induced mucosal cell death in human gastric cells: evidence supporting an apoptotic mechanism.

Authors:  Jacinda J Power; Miranda S Dennis; Maria J Redlak; Thomas A Miller
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.